| Identification | Back Directory | [Name]
C2 Adamantanyl Galactosylceramide (d18:1/2:0) | [CAS]
574738-16-2 | [Synonyms]
C2 Adamantanyl Galactosylceramide (d18:1/2:0)
Tricyclo[3.3.1.13,7]decane-1-acetamide, N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]- | [Molecular Formula]
C36H63NO8 | [MOL File]
574738-16-2.mol | [Molecular Weight]
637.9 |
| Chemical Properties | Back Directory | [Boiling point ]
830.6±65.0 °C(Predicted) | [density ]
1.17±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
powder | [pka]
12.92±0.70(Predicted) | [InChIKey]
JJKSFVGDPSOVJH-WQVUVXLKSA-N | [SMILES]
[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@](NC(CC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3)=O)([H])CO[C@H](O4)[C@H](O)[C@@H](O)[C@@H](O)[C@H]4CO |
| Hazard Information | Back Directory | [Biological Activity]
Adamantyl galactosylceramide (adaGalCer)a glycosphingolipid (GSL) analogmodulates abnormal GSL turnover. It functions as an inhibitor and an alternative substrate to regulate cellular GSL metabolism in a particular manner. AdaGalCer blocks cell sulfatide synthesis and microsomal globotriaosyl ceramide (Gb3) synthesis. It reduces glucosylceramide (GlcCer) levels in normal and lysosomal storage disease (LSD) cells. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|